24,96 €
Nattokinase 100 mg NSK-SD®
Category: Heart and circulatory system
Manufacturer: Kenay GmbH
Comprehensive atherosclerotic and thrombotic prevention
- Supports circulatory system
- Shows anti-atherosclerotic and lipid-lowering effects
- Shows antihypertensive effects
- Shows anticoagulant effects
- Safe for people using anticoagulants
In stock
Volume discounts
Quantity | Price | You Save |
---|---|---|
2 | 32,56 € | Up to 2,71 € |
4 | 31,88 € | Up to 8,14 € |
By buying this product you can collect up to 33 loyalty points. Your cart will total 33 points that can be converted during next order into a voucher of 1,65 €.
More info
Nattokinase 100 mg NSK-SD®
60 capsules
Item Catalog Number: K1014EN
Original product name: Nattokinase 100 mg NSK-SD®
In recent years, Natto has gained the reputation of a superfood. This traditional Japanese dish made from fermented soybeans has a number of health benefits. Natto's health benefits are due to the presence of an enzyme - nattokinase (discovered in the sticky part of Natto). Nattokinase is an enzyme produced by a certain strain of Bacillus subtilis bacteria during the fermentation of soybeans. Nattokinase gained popularity due to its beneficial cardiovascular health effects. This enzyme also helps maintain the balance of the intestinal microbiome.
Patented and safe Nattokinase NSK-SD®
JAPAN BIO SCIENCE LABORATORY has patented a unique modern technology enabling the removal of vitamin K from Nattokinase NSK-SD®.
Vitamin K interacts with warfarin and other blood thinners. Nattokinase NSK-SD® is safe for use in people taking warfarin or other anticoagulants because it does not contain vitamin K.[2,33]
JAPAN BIO SCIENCE LABORATORY is the only Japanese company that can export Nattokinase without vitamin K2.[2,33]
Benefits at a Glance:
- Supports circulatory system and shows antithrombotic activity
- Shows anti-atherosclerotic and lipid-lowering effects
- Shows antihypertensive effects
- Shows anticoagulant effects
- Safe for people using anticoagulants
Nattokinase supports Circulatory system and shows Antithrombotic activity
Nattokinase has beneficial effects in the prevention and treatment of cardiovascular diseases.[3,4] For many years, scientists, especially from Japan, Korea and China, have been constantly researching Nattokinase's role in the prevention and treatment of cardiovascular diseases.[3-6] Nattokinase is considered as safe, powerful, low cost, and all-natural supplement to support heart and cardiovascular health.[3-4,6-9]
Both, animal and human studies has shown beneficial effects of Nattokinase. It supports the circulatory system by thinning the blood and dissolving blood clots.[3,4,10-15] Nattokinase shows an effect on both oxidative injury-mediated arterial thrombosis [3,4,16,17] and inflammation-induced venal thrombosis.
Nattokinase as anti-atherosclerotic and lipid-lowering agent
Atherosclerosis, which is primary cause of many cardiovascular diseases, is also a cause of heart diseases and stroke. Nattokinase shows promising anti-atherosclerotic and lipid-lowering effects. [3-4,18]
Many studies showed anti-atherosclerotic and lipid-lowering effects of Nattokinase supplementation. In a clinical study on rats,[3,4,16,19] Nattokinase and the natto extract supplementation suppressed endothelial's intimal thickening in rats with diagnosed endothelial injury. Other study demonstrated that NK prevented arteriosclerosis by its direct antioxidant effect leading to reduced lipid peroxidation and improved lipid metabolism (inhibition of LDL oxidation).[3,4,20]
One of clinical trials demonstrated that after 26 weeks of Nattokinase supplementation, there was a significant reduction in CCA intima-media thickness (CCA-IMT) and carotid plaque size when compared with the baseline before treatment.[3,4,5,21] Nattokinase may be a great alternative to statins, a commonly used drug to reduce atherosclerosis.
In animal models, nattokinase showed a hypolipidaemic effect and can significantly reduce the increased serum triglycerides, total cholesterol, and LDL cholesterol levels.[3,4,5,22]
Nattokinase as an antihypertensive agent
One study[3,4,24] suggested that nattokinase consumption for 8 weeks caused beneficial changes to blood pressure in patients having hypertension.
Long-term use of antihypertensive drugs causes side effects,[3,4,25]so nattokinase may be a promising alternative for the management of hypertension in patients with diagnosed cardiovascular diseases. Nattokinase supplementation may be a successful additional treatment strategy for patients with hypertension.[3,4,26] Of course, each action requires consultation with the attending physician.
Nattokinase as an anticoagulant effects
One study compared the antithrombotic effects of aspirin and nattokinase. In both in vitro and in vivo tests, nattokinase showed excellent platelet aggregation inhibitory effects.[3,4,27] Long-term use of aspirin comes with serious gastrointestinal side effects and bleeding.[3,4,29] Nattokinase does not cause such a side effects.[3,4,28,29] It may therefore prove to be a very effective, natural and body-friendly way to improve blood flow without the unpleasant side effects from the digestive system associated with long-term aspirin supplementation. [3,4,28]
Supplement Facts
Daily dose: 1 capsule
Amount per day: (1 capsule) | |
---|---|
Nattokinase NSK-SD® 2000 FU/caps. (from fermented soybean extract) |
100 mg |
Ingredients: soy oil; porcine gelatin; fermented soybean extract; softgel: glycerin; colouring agent: beeswax; emulsifying agent: polyglycerol esters of fatty acids; carrier: soy lecithin. |
Contains soy
NSK-SD® is a trademark of Japan Bio-Science Laboratories.
Dosage and Use
Take one (1) capsule daily or as recommended by a healthcare practitioner.
Storage: Store in a closed container at room temperature, out of the reach of small children.
Warnings:
Before you start using any dietary supplement, consult your doctor.
Dietary supplements are not medicines.
Do not exceed the recommended daily dose.
Dietary supplements cannot be used as a substitute for a varied diet.
Do not use in case of hypersensitivity to any ingredient of the preparation.
The product should not be used by pregnant or breastfeeding women and children and adolescents under 18 years of age.
- http://www.jbsl-net.com/english/product/nsk.php
- http://j-nattokinase.org/en/jnka_nattou_01.html
- H Chen, E M McGowan, N Ren, S] Lal,] N Nassif, F Shad-Kaneez, Xianqin Qu, Yiguang Lin "Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases"
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043915/
- Yunqi Weng, Jian Yao, Sawyer Sparks, Kevin Yueju Wang "Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease"
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372539/
- Nagata C., Wada K., Tamura T., Konishi K., Goto Y., Koda S., Kawachi T., Tsuji M., Nakamura K. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: The Takayama study. Am. J. Clin. Nutr. 2016 doi: 10.3945/ajcn.116.137281.
- Dabbagh F., Negahdaripour M., Berenjian A., Behfar A., Mohammadi F., Zamani M., Irajie C., Ghasemi Y. Nattokinase: Production and application. Appl. Microbiol. Biotechnol. 2014;98:9199–9206.
- Huang Y., Ding S., Liu M., Gao C., Yang J., Zhang X., Ding B. Ultrasmall and anionic starch nanospheres: Formation and vitro thrombolytic behavior study. Carbohydr. Polym. 2013;96:426–434.
- Fujita M., Hong K., Ito Y., Misawa S., Takeuchi N., Kariya K., Nishimuro S. Transport of nattokinase across the rat intestinal tract. Biol. Pharm. Bull. 1995;18:1194–1196.
- Fujita M., Ohnishi K., Takaoka S., Ogasawara K., Fukuyama R., Nakamuta H. Antihypertensive effects of continuous oral administration of nattokinase and its fragments in spontaneously hypertensive rats. Biol. Pharm. Bull. 2011;34:1696–1701.
- Sumi H., Hamada H., Nakanishi K., Hiratani H. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol. 1990;84:139–143.
- Jensen G.S., Lenninger M., Ero M.P., Benson K.F. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: Results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integr. Blood Press. Control. 2016;9:95–104.
- Kurosawa Y., Nirengi S., Homma T., Esaki K., Ohta M., Clark J.F., Hamaoka T. A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Sci. Rep.
- Lampe B.J., English J.C. Toxicological assessment of nattokinase derived from Bacillus subtilis var. natto. Food Chem. Toxicol. 2016;88:87–99.
- Suzuki Y., Kondo K., Matsumoto Y., Zhao B.-Q., Otsuguro K., Maeda T., Tsukamoto Y., Urano T., Umemura K. Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery. Life Sci. 2003;73:1289–1298.
- Jang J.-Y., Kim T.-S., Cai J., Kim J., Kim Y., Shin K., Kim K.-S., Park S.K., Lee S.-P., Choi E.-K., et al. Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation. Lab. Anim. Res. 2013;29:221–225.
- Lusis AJ. Atherosclerosis. Nature. 2000;407:233–241.
- Suzuki Y, Kondo K, Ichise H, Tsukamoto Y, Urano T, Umemura K. Dietary supplementation with fermented soybeans suppresses intimal thickening. Nutrition. 2003;19:261–264.
- Iwai K, Nakaya N, Kawasaki Y, Matsue H. Antioxidative functions of natto, a kind of fermented soybeans: effect on LDL oxidation and lipid metabolism in cholesterol-fed rats. J Agric Food Chem. 2002;50:3597–3601.
- Ren N, Chen H, Li Y, McGowan E, Lin Y. A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia. Nat Med J China. 2017;97:2038–2042.
- Wu D-J, Lin C-S, Lee M-Y. Lipid-lowering effect of nattokinase in patients with primary hypercholesterolemia. Acta Cardiologica Sinica. 2009;25:26–30.
- Okamoto A, Hanagata H, Kawamura Y, Yanagida F. Anti-hypertensive substances in fermented soybean, natto. Plant Foods Hum Nutr. 1995;47:39–47.
- Jensen GS, Lenninger M, Ero MP, Benson KF. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integr Blood Press Control. 2016;9:95–104.
- Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community. J Clin Hypertens. 2014;16:14–26.
- Suwanmanon K, Hsieh P-C. Effect of γ-aminobutyric acid and nattokinase-enriched fermented beans on the blood pressure of spontaneously hypertensive and normotensive Wistar–Kyoto rats. J Food Drug Anal. 2014;22:485–491.
- Jang JY, Kim TS, Cai J, et al. Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation. Lab Anim Res. 2013;29:221–225
- Wang J-M, Chen H-Y, Cheng S-M, Chen S-H, Yang L-L, Cheng F-C. Nattokinase reduces brain infarction, fibrinogen and activated partial thromboplastin time against cerebral ischemia-reperfusion injury. J Food Drug Anal.
- Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86.
- Hsu R-L, Lee K-T, Wang J-H, Lee LY, Chen RP. Amyloid-degrading ability of nattokinase from Bacillus subtilis natto. J Agric Food Chem. 2008;57:503–508.
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043915/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394349/
- http://www.jbsl-net.com/english/